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OBJECTIVES: Access to the pterygopalatine fossa is very difficult due to its complex anatomy. Therefore, an open
approach is traditionally used, but morbidity is unavoidable. To overcome this problem, an endoscopic
endonasal approach was developed as a minimally invasive procedure. The surgical aim of the present study was
to evaluate the utility of the endoscopic endonasal approach for the management of both benign and
malignant tumors of the pterygopalatine fossa.
METHOD: We report our experience with the endoscopic endonasal approach for the management of both
benign and malignant tumors and summarize recent recommendations. A total of 13 patients underwent
surgery via the endoscopic endonasal approach for pterygopalatine fossa masses from 2014 to 2016. This case
group consisted of 12 benign tumors (10 juvenile nasopharyngeal angiofibromas and two schwannomas) and
one malignant tumor.
RESULTS: No recurrent tumor developed during the follow-up period. One residual tumor (juvenile nasopharyn-
geal angiofibroma) that remained in the cavernous sinus was stable. There were no significant complications.
Typical sequelae included hypesthesia of the maxillary nerve, trismus, and dry eye syndrome.
CONCLUSION: The low frequency of complications together with the high efficacy of resection support the use
of the endoscopic endonasal approach as a feasible, safe, and beneficial technique for the management of
masses in the pterygopalatine fossa.
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’ INTRODUCTION
The pterygopalatine fossa (PPF) is a narrow, inverted,
cone-shaped space that is localized posteriorly to the dorsal
wall of the maxillary sinus and consists of fat, the ptery-
gopalatine ganglion, the Vidian nerve, the maxillary nerve
(V2), and terminal branches of the maxillary artery. The
anteroposterior order of the layers is as follows: fat, blood
vessels, and neural structures. The posterior wall of the PPF
is formed by the base of the pterygoid process and is bor-
dered by the palatine bone medially and the middle cranial
fossa cranially. Laterally, the PPF is open to the infratemporal
fossa (ITF) via the pterygomaxillary fissure. The Vidian canal
opens into the posterior part of the PPF and contains the
Vidian nerve and artery. The palatovaginal (pharyngeal) canal
is located medially to the Vidian canal, and the sphenopalatine
foramen is a communication medial to the nasal cavity via
the palatine bone. The descending palatine canal continues
inferiorly to the apex of the PPT and opens into the oral
cavity via the greater and lesser palatine foramina. The
foramen rotundum, containing V2, is a communication that
is located cranially to the middle crania fossa. The inferior
orbital fissure is open anterosuperiorly to the orbit. The PPF
is a very complex anatomical area of the skull base with
interconnections to the head and neck (Figure 1) (1–3).
Accessing the PPF is difficult, which is traditionally
approached via an open method, such as lateral rhinotomy,
midfacial degloving, facial translocation, transantral max-
illectomy, and the Fisch C and D procedures. Although these
procedures provide good exposure of the PPF, they are often
complicated by unacceptable facial scaring and deformity as
well as dysfunction of the facial and infraorbital nerves.
Endoscopic sinus surgery is now a standard procedure for
inflammatory sinonasal disease, and more recently, it has
been adopted as a basic approach for the treatment of benign
sinonasal tumors, such as inverted papilloma or juvenileDOI: 10.6061/clinics/2017(09)06
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nasopharyngeal angiofibroma (JNA) (4,5). Advances in endo-
scopic endonasal surgery, such as interventional radiology
with preoperative embolization, improved instrumentation,
computer-based navigation, and hemostatic materials, as well
as a two-surgeon technique, have enabled endoscopic endo-
nasal access to tumors of the PPF (6). Primary tumors of the
PPF, such as schwannomas of V2, are rare, while sinonasal
tumors more frequently extend into the PPF (7). Hence,
relatively few studies (most of which were case series involv-
ing low numbers of patients) have investigated the endo-
scopic endonasal approach (EEA) to access tumors of the PPF
(8–11). Our study follows the recommendations of previous
authors, who called for the publication of more cases. There-
fore, the surgical aim of the present study was to evaluate the
utility of the EEA for the management of both benign and
malignant tumors of the PPF. The present study included the
highest number of cases per year among related published
reports. Adequate follow-up and appropriate postoperative
care (a novelty of trismus physiotherapy) were emphasized.
’ MATERIAL AND METHODS
The surgical records of 13 patients who underwent resec-
tion of a tumor of the PPF via the EEA at the Department
of Otorhinolaryngology and Head and Neck Surgery,
1st Faculty of Medicine, Charles University, University
Hospital Motol, Prague, Czech Republic from April 2014 to
March 2016 were retrospectively reviewed. All patients who
underwent resection via the EEA for a tumor of the PPF
during this period were enrolled. The study protocol was
approved by the institutional review board of our hospital,
and written informed consent was obtained from all patients.
Diagnosis was based on patient history and the results of
complete clinical otorhinolaryngological examinations, which
included nasal endoscopy, computed tomography (CT), and
magnetic resonance imaging (MRI). No biopsy was per-
formed for 10 patients with clinical and imaging findings
that were consistent with a diagnosis of JNA. For confirmed
cases of JNA, preoperative angiography with embolization
Figure 1 - CT anatomy of the pterygopalatine fossa (asterisk). (A) An axial image showing a communication to the ITF via the
pterygomaxillary fissure (long arrow) to the middle cranial fossa via the foramen rotundum (dashed arrow) and to the nasal cavity via
the sphenopalatine foramen (short arrow). (B) An axial image in a different plane showing the Vidian canal running to the foramen
lacerum (short arrow). (C) A coronal image showing a communication to the nasal cavity via the sphenopalatine foramen (short arrow)
to the orbit via the infraorbital fissure (dashed arrow) and to the ITF via the pterygomaxillary fissure (long arrow). (D) A sagittal image
showing the greater palatine canal (short arrow) running to the oral cavity with a communication to the orbit via the infraorbital
fissure (dashed arrow) and to the middle cranial fossa via the foramen rotundum (long arrow).
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was performed one day before surgery. Two patients had
schwannomas of V2: one was biopsied from a portion of the
tumor in the lateral part of the choana at an otorhinolaryn-
gology department in another hospital, and the second
was diagnosed with a high probability based on preopera-
tive assessment and was subsequently confirmed by peri-
operative biopsy. The last patient in this cohort was the
only case with malignancy. In this patient, undifferentiated
sinonasal carcinoma (cT4b cN0) infiltrated the bilateral nasal
cavities, bilateral ethmoids, unilateral maxillary and sphe-
noid sinuses, unilateral PPF, and the brain in the anterior
cranial fossa. This was the only case to undergo combination
surgery via the EEA for the management of the sinonasal
and pterygopalatine portions of the tumor and bifrontal
craniotomy for the intracranial portion. This patient also
received adjuvant chemoradiotherapy. Postoperative follow-
up of all cases included clinical examination with an
emphasis on endoscopic evaluation and radiological workup
according to European guidelines (4).
All surgeries were performed under general anesthesia. In
11 cases of sinonasal tumors extending to the PPF (10 cases of
JNA and one case of undifferentiated sinonasal carcinoma),
the tumor in the nasal cavity blocking the approach to the
posterior wall of the maxillary sinus was resected using a
piecemeal technique to expose the surgical intranasal cor-
ridor as the first step. The nasal septum was resected in cases
of undifferentiated sinonasal carcinomas due to tumor infil-
tration and in schwannoma cases with large extensions to
the middle cranial fossa, ITF, and cheek to safely achieve a
larger working space. The second step (the ethmoid step)
involved anteroposterior ethmoidectomy, sphenoidectomy,
extensive supraturbinal antrostomy, and partial resection of
the middle (dorsal part) and superior turbinates. Antrostomy
was extended to the posterior wall of the maxillary sinus.
In cases of infiltration of undifferentiated sinonasal carci-
noma, complete medial maxillectomy was performed. Com-
plete medial maxillectomy was also performed in cases of
giant schwannoma (P11) extending from the PPF through the
ITF laterally from the sagittal plane passing at the lateral
border of the maxillary sinus to ensure sufficient lateral
access. The sphenopalatine foramen and sphenopalatine
artery entering the nasal cavity near the tip of the middle
turbinate was identified as an important surgical landmark.
The posterior wall of the maxillary sinus was then removed
while preserving the periosteum of the PPF as the third step.
Preservation of the periosteum surfacing the PPF was helpful
for subsequent identification of the Vidian nerve medially
and the maxillary nerve superolaterally. The extent of the
surgical window in the posterior wall was dependent on the
exact location and extent of the tumor in the PPF. The extent
of drilling around the sphenopalatine foramen was also
determined based on the extent of PPF involvement. The
fourth step was appropriate resection of the PPF tumor. The
first structure encountered after incision of the PPF perios-
teum was fat tissue, followed by blood vessels. The distal
branches of the maxillary artery (Vidian, descending palatal,
and palatovaginal branches) and its main trunk were
identified and cauterized. The neural structures all lie deeper
than this plexus of arteries. During blunt dissection of the
tumor, maximal effort was taken to preserve the maxillary
and infraorbital nerves, the greater and lesser palatine
nerves, and the Vidian nerve (if they were not involved in
the tumor) to minimize neurological morbidity. The poster-
olateral border of dissection was the anterior surface of the
lateral pterygoid muscle. Navigation with CT/MRI fusion
and perioperative frozen sections were used to ensure safe
radical resection. The final step consisted of drilling around
the Vidian canal to prevent JNA recurrence. In case of
malignancy, the pterygoid root and plates were also resected.
’ RESULTS
The group of 13 patients with tumors of the PPF who were
treated via the EEA included 11 males and 2 females with a
mean age of 21.8 (range, 15–56) years (Table 1). The following
symptoms were observed among these 13 patients: unilateral
nasal obstruction in 12 patients, epistaxis in six patients,
and pain in four patients. One patient (P12) with a smaller
schwannoma had no clinical symptoms with incidental
finding on MRI. A total of 12 patients had benign tumors:
10 cases of JNA (3x IIa, 1x IIb, 5x IIc, and 1x IIIb according to
the Radkowski grading system, i.e., six cases with extension
of the tumor out of the PPF to the ITF – grade IIc and/or
intracranially – grade IIIb) and two with schwannomas
arising from the maxillary nerve. Representative cases of
JNA (P5) and schwannoma (P11) are shown in Figures 2
and 3, respectively. One malignant tumor was undifferen-
tiated sinonasal carcinoma (cT4b cN0) that infiltrated the
bilateral nasal cavities, bilateral ethmoids, unilateral max-
illary and sphenoid sinuses, and unilateral PPF, including
the intracranial portion with brain infiltration (Figure 4).
This patient was the only one that underwent combination
surgery, i.e., EEA for the management of the sinonasal and
pterygopalatine portions of the tumor and bifrontal cra-
niotomy for the intracranial portion. This patient was also
the only one to receive adjuvant chemoradiotherapy using
proton beam therapy. The optimal management of sinonasal
undifferentiated carcinoma remains unclear. Treatment stra-
tegies vary among institutions, and no single approach has
demonstrated a clear therapeutic advantage. Surgery as the
primary mode of treatment with postoperative chemoradio-
therapy is acceptable for patients with resectable disease
and improves oncologic control (4,13). Ten tumors (all JNAs)
originated in the nasopharynx with extension to the PPF
(in six cases, more laterally to the ITF). Both schwannomas of
V2 were primary tumors of the PPF. Seven patients with
JNA in this cohort underwent primary surgery, and three
were revision surgeries. Case P2 underwent external lateral
rhinotomy 2 years before endoscopic revision for a growing
residual tumor in the PPF and ITF. Case P7 was a giant
JNA that was endoscopically resected three times in 2 years
at another otorhinolaryngology department. The last surgery
was performed without preoperative embolization due to
the blood supply from the internal carotid artery. This sur-
gery was stopped prematurely due to uncontrollable bleed-
ing from the tumor. Subsequent multiple attempts for nasal
tamponade removal were unsuccessful due to continued
uncontrollable bleeding, and the patient was transported to
the Department of Otorhinolaryngology and Head and Neck
Surgery, 1st Faculty of Medicine, Charles University with a
residual JNA in the PPF and ITF. Subsequent R0 endoscopic
resection was performed without preoperative embolization.
JNA case P8 underwent endoscopic resection twice in 2 years
at another otorhinolaryngology department. A residual
tumor remained in the PPF and ITF; therefore, the patient
underwent revision surgery at the Department of Otorhino-
laryngology and Head and Neck Surgery, 1st Faculty of
Medicine, Charles University.
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Of the 13 patients, 12 had no microscopic residual disease
(R0). In case of JNA P6 (stadium Radkowski grade 3b –
intracranial extension with cavernous sinus invasion),
a residual tumor of approximately 1 cm in diameter was
left in the cavernous sinus area. Repetitive postoperative
MRI at 6-month intervals showed that the residual tumor
was stable. No development of a new residual or recurrent
tumor was observed in any of the other cases during the
follow-up period.
The mean blood loss during surgery was 550 (range, 100–
1,700) mL. Ten patients received intraoperative transfusions.
No significant intraoperative neuro/vascular complications
occurred. The mean duration of postoperative hospitaliza-
tion was 5.8 (range, 4–12) days. There were no postopera-
tive infections or systemic complications. Postoperative
neural dysfunction was observed in eight cases: four cases
of transient V2 hypesthesia and four cases of permanent V2
hypesthesia (two cases of V2 schwannoma; JNA Radkowski
grade 3b in case P6 and JNA Radkowski grade 2c after
three previous non-radical surgeries in case P7). Dry eye
syndrome due to pterygopalatine ganglion dysfunction occ-
urred in one case. Permanent trismus was present in two
cases: one with a JNA (case P7) and one with a carcinoma
(case P13), in which deterioration mainly occurred after
chemoradiotherapy.
’ DISCUSSION
The management of PPF lesions represents one of the areas
in which open surgery has been shifted back to the stage of
the last decade. Endoscopic endonasal surgery is performed
for lesions with boundaries that extend beyond the paranasal
cavities to the PPF and ITF (12) and is indicated not only
for inflammatory disease but also for benign and even
malignant tumors that are very difficult to reach in this
anatomical region (13). The use of a natural pathway via the
nasal and paranasal cavities reduces morbidity associated
with the access route compared to the external approach.
Cosmesis, especially external scarring, is also an important
factor in favor of the EEA. Angled endoscopes provide much
better visualization of the PPF, which is difficult to access.
A profound knowledge of the PPF and ITF and their
neighboring spaces is essential for performing safe surgery.
The creation of an appropriate endoscopic surgical corridor
is crucial to allow safe manipulation, tissue dissection,
and hemostasis. It is more difficult to manage minor bleed-
ing using the EEA than when using an open approach.
In addition, a narrower variety of instruments are usable for
mass dissection in the EEA.
Biopsy as well as radical resection of PPF tumors via the
EEA have been reported in the literature (14-16). The case
series reported by Battaglia et al. (11) describing 37 patients
who were treated during a 13-year period is among the most
extensive. Our study follows the recommendations of this
group, which called for the publication of more cases. The
present study included the highest number of cases per year
among related published reports.
The PPF is one of the most anatomically complex regions
of the human body because it contains a range of vital neural
and vascular structures with interconnections to the orbit,
middle cranial fossa, nasal cavity, and oral cavity (17,18).
All of these structures must be carefully considered when
planning surgery and especially during the surgical proce-
dure. Preservation of the neural structures in the PPF is
Figure 2 - Juvenile nasopharyngeal angiofibroma, case P5, Radkowski grade 2c. Axial CT (A) and MRI T2-weighted scans (B) showing a
mass in the dorsal two thirds of the left nasal cavity and in the sphenoid sinus (marked by S) with a bulky extension to the
pterygopalatine fossa and the ITF. Extensive anteroposterior widening of the sphenopalatine foramen is marked by arrows. (C) An axial
MRI T2-weighted scan one year after surgery demonstrating no evidence of disease.
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necessary to limit surgical morbidity. Vascular complications
are mostly caused by damage to branches of the maxillary
artery. The management of massive blood loss is one of the
limiting steps of the EEA to access the PPF.
No major intraoperative complications occurred among
the 13 patients in this cohort, while 9 (69.2%) developed
minor complications, which included transient complications
in three cases (V2 hypesthesia and trismus). Permanent post-
operative sequelae were present in 6 (46.1%) patients, which
included dry eye syndrome in one case, V2 hypesthesia
in three cases, V2 hypesthesia with trismus in one case,
and trismus in one case. V2 damage was associated with
extensive PPF involvement in advanced JNA and with
schwannomas arising from V2. Resection extending to the
pterygoid muscle is thought to induce postoperative trismus.
Therefore, we recommend trismus physiotherapy for all PPF
surgeries. Despite this precaution, permanent trismus was
observed in two cases. Case P7 developed slight permanent
trismus after surgery for JNA, which might have resulted
from the three previous non-radical surgeries. One case of
carcinoma (case P13) developed permanent trismus after
postoperative chemoradiotherapy. In case P11 with giant
trigeminal schwannoma originating from the pterygopala-
tine fossa, we succeeded with the treatment of postoperative
trismus by physiotherapy, and the patient is now free of this
symptom. All other patients did not develop trismus,
presumably because of early rehabilitation of mouth opening
starting on the 2nd to 5th postoperative days. The patients
were instructed during self-rehabilitation to perform a daily
exercise of mouth opening.
The use of total endoscopic endonasal management of
residual/recurrent disease located in the PPF remains
controversial. There were three such cases in our study,
all of which were JNAs. Cases P7 and P8 were treated first
by repeated endonasal endoscopy via the EEA at other
departments. After careful evaluation of images, we found
no resections of the posterior wall of the maxillary sinus.
Therefore, we expected no previous manipulation in the PPF
and no scarring. Our presumptions were confirmed during
the surgeries; thus, radical endonasal endoscopic resections
were performed. The third patient (P2) was the last who
underwent external surgery for JNA at our Department of
Otorhinolaryngology. Additionally, in this case, there was no
intervention in the PPF through the posterior wall of the
maxillary sinus during the primary external surgery; thus,
subsequent revision endoscopic surgery for a growing mass
in the PPF was successful.
The low frequency of complications together with the
high efficacy of resection (no recurrence and only one
stable persistent residuum in the cavernous sinus) support
Figure 3 - Schwannoma of V2, case P11. Coronal (A) and axial CT (B) scans showing considerable deformation of the splanchno and
neurocranium on the right side. A mass (74 x 65 x 61 mm) arising from V2 in the pterygopalatine fossa with bulky extension to the ITF,
cheek, and middle cranial fossa via the foramen rotundum, which is extremely enlarged (long arrow) – see side difference. The
schwannoma pushed the posterior wall of the maxillary sinus forward (short arrow) and the pterygoid process backward (dashed
arrow) – also see side differences. (C) An axial T1-weighted MRI scan with gadolinium contrast showing the margin between the tumor
and soft tissue. (D) A sagittal T2-weighted MRI scan showing that the tumor is pressing on the orbital apex via the infraorbital fissure
(long arrow) with an intracranial portion (24 x 21 x 20 mm) in the middle cranial fossa (dotted line). Postoperative T2-weighted MRI
scans in the sagittal (E) and axial (F) planes demonstrate no evidence of disease 21 months after surgery. A nasoseptal flap (long arrow)
was used to cover exposed dura mater of the middle cranial fossa, although no clear leakage of cerebrospinal fluid was observed
intraoperatively. Considerable retraction of soft tissue into the postresection empty space of the cheek and ITF is visible on the axial
MRI – compare (C) and (F).
559
CLINICS 2017;72(9):554-561 Endoscopy of the pterygopalatine fossa
Plza´k J et al.
endoscopic endonasal surgery as a feasible, safe, and
beneficial technique for the management of masses in the
PPF. The following are fundamental prerequisites to safely
and effectively performing this approach: (1) thorough
preoperative evaluation of imaging examinations (MRI/CT),
(2) the availability of adequate technical equipment (endo-
scopes, endoscopic skull base instruments, a navigation
system, hemostatic facilities, etc.), and (3) adequate experi-
ence and skill of the surgeon in the use of advanced
endoscopic techniques.
Figure 4 - Sinonasal undifferentiated carcinoma T4b, case P13. Axial PET/CT (A) and axial (B) and coronal (D) MRI T1-weighted with
gadolinium contrast images showing a mass in the bilateral nasal cavities, bilateral ethmoid sinuses, right maxillary and sphenoid
sinuses, and right pterygopalatine fossa (arrows) with an intracranial portion with brain infiltration. Axial (C) and coronal (E) MRI T1-
weighted scans with gadolinium contrast demonstrating no evidence of disease two years after surgery and postoperative
chemoradiotherapy.
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